Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Q Biomed Inc (QBIO)

Q Biomed Inc (QBIO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Q BioMed Responds to OTC Markets Request for Clarity on Promotional Activity

New York, New York--(Newsfile Corp. - June 24, 2019) - Q BioMed Inc. (OTCQB: QBIO), is providing this response at the request of the OTC markets inquiry into recent expanded investor awareness activities...

QBIO : 1.2900 (-2.27%)
Latest Biotechnology Advancements may be Key to Unlock new Autism Treatments

According to the Centers for Disease Control, autism affects an estimated 1 in 59 children in the United States today. The Autism Speaks website defines the main problem for researchers/practitioners...

QBIO : 1.2900 (-2.27%)
GERN : 1.24 (+2.48%)
INSM : 21.53 (-1.06%)
PHAS : 10.17 (-5.13%)
CMRX : 3.60 (-2.17%)
Q BioMed's Diagnostic Kit Designed to Serve Unmet Need for 70 Million Glaucoma Sufferers

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has released a new Company Spotlight article on high profile biomedical...

QBIO : 1.2900 (-2.27%)
OTC Markets Group Announces Gold Sponsorship of 31st Annual ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market company presentations...

EVLLF : 0.7059 (+1.42%)
TRLFF : 0.2452 (+9.66%)
AITB : 5.24 (+2.34%)
BICXD : 4.5400 (-9.02%)
MMNFF : 2.2200 (unch)
ATEA : 5.9500 (+5.87%)
CWBHF : 16.1200 (-2.30%)
CVSI : 4.2000 (+0.96%)
DUOT : 0.7100 (+1.43%)
CRLBF : 9.1600 (-2.03%)
ARREF : 0.5005 (-4.30%)
CLOK : 0.9005 (-4.80%)
MLCPF : 3.5200 (+11.47%)
CNBX : 0.3300 (-2.94%)
HEOFF : 0.9250 (-0.46%)
MJARF : 1.1900 (+1.71%)
ALEAF : 0.9161 (-0.32%)
OTCM : 33.0000 (+2.80%)
NUPMF : 1.8900 (+0.53%)
GLDLF : 0.6900 (+3.20%)
NMUS : 0.6500 (-9.52%)
NLST : 0.3680 (-5.62%)
GBPT : 7.7500 (unch)
IMLFF : 0.2520 (-1.83%)
KSHB : 4.9300 (-1.99%)
CORVF : 1.7135 (+4.91%)
ELLXF : 2.7700 (+1.02%)
RSSS : 2.4920 (-5.96%)
ISYRF : 1.0340 (+17.51%)
FLUX : 0.9000 (-28.00%)
NWGI : 0.3525 (-4.73%)
QBIO : 1.2900 (-2.27%)
WIZD : 0.1850 (+8.82%)
MRMD : 1.6900 (-1.74%)
GRWG : 3.7100 (+9.12%)
BRTI : 0.1599 (+6.60%)
GTBP : 0.2450 (-2.00%)
MRIC : 3.89 (+2.10%)
DYAI : 4.98 (-0.40%)
GTBIF : 9.4070 (+0.50%)
MTAFF : 0.7700 (-3.16%)
EMHTF : 1.7700 (+1.72%)
ITHUF : 2.9629 (+4.70%)
ALYE : 4.0000 (+14.29%)
VTLR : 0.0920 (-22.62%)
ARHH : 1.2000 (+1.69%)
OWCP : 0.0114 (-4.20%)
STLHF : 0.6542 (+2.22%)
PPCB : 0.0068 (-9.33%)
ARTH : 0.3250 (+0.78%)
ACRGF : 14.9500 (+3.82%)
Q Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market

Goldman Small Cap Research, a stock market research firm specializing in the small cap and microcap sectors, announced today that it has released a new Company Spotlight article on high profile biomedical...

QBIO : 1.2900 (-2.27%)
Demand for New Glaucoma Therapies Has Greatest Potential to Drive Value for Q BioMed's Shareholders

NEW YORK, NY / ACCESSWIRE / February 8, 2019 / Q BioMed (OTCQB: QBIO) has announced that it is bringing innovation to the treatment of Glaucoma- the the leading cause of irreversible blindness globally....

QBIO : 1.2900 (-2.27%)
Q BioMed Responds to OTC Markets Request for Clarity on Investor Awareness Activity

Q BioMed Inc. (OTCQB: QBIO), is providing this response at the request of the OTC markets inquiry into recent expanded investor awareness activities undertaken by the Company.

QBIO : 1.2900 (-2.27%)
Biotech Companies Introduce New Treatments as Concern Over Cancer Rises

Cancer is among one of the leading causes of death around the globe; namely, in 2018, there were a total estimated 18.1 million new cases worldwide. The International Agency for Research on Cancer (IARC)...

QBIO : 1.2900 (-2.27%)
CELG : 90.87 (-0.72%)
INCY : 80.23 (+0.44%)
SGEN : 75.17 (+18.98%)
CELGZ : 0.50 (+1.67%)
NKTR : 31.98 (-1.57%)
Biotechnology Companies See Growth in Optic Treatment Sectors

The vast number of people in need of medical treatment has grown tremendously over the years. Some cases are a result of environmental changes, yet others can be caused by genetics. Regardless, there is...

QBIO : 1.2900 (-2.27%)
AERI : 24.02 (-1.44%)
NVS : 90.23 (+1.20%)
VSTM : 1.49 (-3.25%)
AXSM : 25.02 (-2.15%)
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City

NEW YORK , Feb. 5, 2019 /PRNewswire/ --  www.FinancialBuzz.com , a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with...

QBIO : 1.2900 (-2.27%)
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City

www.FinancialBuzz.com, a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with Q Biomed Inc. (OTCQB: QBIO) Chairman and CEO, Denis...

QBIO : 1.2900 (-2.27%)
TPIV : 8.34 (+0.60%)
FinancialBuzz.com Exclusive Interview With Chairman and CEO Denis Corin of Q BioMed Inc. Live From Times Square in New York City

www.FinancialBuzz.com, a respected source in the financial news media space located on Wall Street, today announces an exclusive video interview with Q Biomed Inc. (OTCQB: QBIO) Chairman and CEO, Denis...

QBIO : 1.2900 (-2.27%)
TPIV : 8.34 (+0.60%)
Q BioMed Seeks Multi-billion Dollar Opportunity with New Glaucoma Treatment Candidate

NEW YORK, NY / ACCESSWIRE / January 28, 2019 / Shares of Q BioMed Inc. (OTCQB: QBIO) rose on heavy volume after the company announced that a new collaboration among researchers at McMaster University,...

QBIO : 1.2900 (-2.27%)
Q BioMed Adds Clinical Psychologist at Yale's Child Study Center, Dr. Pamela Ventola to Advisory Committee for QBM-001

NEW YORK , January 16, 2019 /PRNewswire/ --

QBIO : 1.2900 (-2.27%)
Q BioMed Adds Clinical Psychologist at Yale's Child Study Center, Dr. Pamela Ventola to Advisory Committee for QBM-001

-- Strategy and Clinical Trial Design Specialist Provides Expertise for the Clinical Trial Design and Regulatory Requirements of QBM-001

QBIO : 1.2900 (-2.27%)
Denis Corin, CEO, of Q BioMed Inc. Provides Key Update and Outlook in a New Audio Interview with SmallCapVoice.com

SmallCapVoice.com, Inc. (SCV) and Q BioMed Inc. (OTCQB: QBIO) (the "Company"), a commercial stage biotechnology company, announced today that a new audio interview with the Company is now available.

QBIO : 1.2900 (-2.27%)
Q BioMed Inc Provides Shareholder Update

Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotechnology company provides the following update to its shareholders and interested investors.

QBIO : 1.2900 (-2.27%)
Q BioMed Inc Provides Shareholder Update

NEW YORK , January 8, 2019 /PRNewswire/ --

QBIO : 1.2900 (-2.27%)

Van Meerten Stock Picks

Tetra Tech - Pollution Control
My Stock Pick of the Day belongs to the pollution control company Tetra Tech(TTEK).
TTEK +0.54
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar